Tag Archives: Umer Raffat

Amgen’s osteoporosis med almost a home run in latest trial; fate now murky on heart safety

The News: Amgen Inc. (Thousand Oaks CA) and UCB SA (Brussels) no longer expect their experimental osteoporosis drug to win US approval this year after a higher rate of serious… Read more »

Mylan’s EpiPen profitable despite recalls, lawsuits; stock price immune to ethics rants

Mylan NV (Amsterdam) is facing a new class-action lawsuit related to the price hikes of it EpiPen devices. The lawsuit was filed in federal court in Tacoma, Washington on Monday… Read more »

Trump tweet on drug prices sinks pharma shares; what’s next, doctors’ wages? Not.

Steve’s Take: President Trump’s morning ritual continues to enthrall millions, but occasionally causes Wall Street analysts covering the pharma industry to reach for their bottle of Maalox. After House Republicans… Read more »

Teva’s CEO Vigodman history; sudden departure calls for fearless successor

The News: Teva Pharmaceutical Industries Ltd. (Petach Tikva ISR) suddenly found itself without a permanent CEO on Tuesday (February 7, 2017) after Erez Vigodman stepped down, leaving new management to… Read more »

Feds charge Heritage execs with price fixing; DOJ ringing out 2016 on a roll against Pharma offenses

The former chief executive and former president of generic drug company Heritage Pharmaceuticals Inc. (Eatontown, NJ) have been charged with conspiring to fix prices, the first charges in a continuing… Read more »

Valeant stock plunges anew on dismal 3Q results; behold another pharma Sisyphus

After an already noisy year, Valeant Pharmaceuticals International Inc. (Laval Québec) once again took investors off guard–this time, on Election Day–as new management cut the annual profit forecast to well… Read more »

Mylan’s EpiPen faces competition from Kaleo Pharma; just what the doctor ordered

Privately held drugmaker Kaleo Inc. (Richmond VA), the main competitor to Mylan NV’s (Amsterdam) EpiPen, announced plans on Wednesday (October 26, 2016) for a US relaunch of its Auvi-Q injector… Read more »

Mylan to Reduce Cost of EpiPen as Pressure Mounts; Not All Patients to Benefit

Mylan NV (Amsterdam) on Thursday took some steps to alleviate patients’ cost burden for its $600 EpiPen emergency allergy shots following pressure from politicians including presidential candidate Hillary Clinton, who… Read more »